Genetic Study of Amyotrophic Lateral Sclerosis in Norway
ConditionAmyotrophic Lateral Sclerosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16-100
SponsorSykehuset Telemark
About this trial
The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.
Eligibility criteria
Qualifiers
Probable or definite ALS
Eligible to consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Observation
Treatment groups
1,200 Participants
are divided into 1 treatment groupLocations
17Haukeland University Hospital, Department of Neurology Bergen Norway
Nordland Hospital Trust, Department of Neurology Bodø Norway
Vestre Viken Hospital Trust, Department of Neurology Drammen Norway
Førde Hospital Trust, Department of Neurology Førde Norway
Sponsors and collaborators
Sykehuset Telemark
Lead sponsor
ALS Norge
Collaborator
Helse Sor-Ost
Collaborator
Source ClinicalTrials.gov